ArticleFrontiers in molecular biosciences2023

Exploring potent aldose reductase inhibitors for anti-diabetic (anti-hyperglycemic) therapy: integrating structure-based drug design, and MMGBSA approaches.

Muhammad Shahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.